Catherine T. Doherty sold $935K of Quest Diagnostics Incorporated (DGX)

Executed Mar 5 2025, disclosed Mar 7 2025, 2 days later.

Value, as filed

$935K

5,370 sh × $174.13

Executed

Mar 5 2025

the trade date, as filed

Disclosed

Mar 7 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Catherine T. Doherty EVP, Regional Businesses profile →

Catherine T. Doherty (EVP, Regional Businesses) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $5.3M of DGX (25,814 sh across 4 lots, as filed), executed Feb 13.

The name

DGX

Quest Diagnostics Incorporated DGX · Healthcare · 49 filings in 24 months ticker →

Healthcare · Quest Diagnostics Incorporated provides diagnostic testing and services in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Catherine T. Doherty in DGX

DGXSALE Quest Diagnostics Incorporated $1.1M
5,558 sh × $206.21
Exec Mar 5
Filed Mar 6 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $131K
632 sh × $207.73
Exec Mar 3
Filed Mar 4 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $294K
1,433 sh × $204.83
Exec Feb 19
Filed Feb 20 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $5.3M
25,814 sh across 4 lots
Exec Feb 13
Filed Feb 17 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $126K
716 sh × $175.79
Exec Mar 4 2025
Filed Mar 5 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $142K
824 sh × $172.61
Exec Feb 27 2025
Filed Feb 28 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $154K
899 sh × $170.99
Exec Feb 20 2025
Filed Feb 21 2025 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $5.4M
33,103 sh across 2 lots
Exec Nov 27 2024
Filed Dec 2 2024 · 5:30 PM ET